Childhood malignant tumors. Concurrent chemotherapy with dactinomycin and vincristine sulfate.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003609:Dactinomycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008649:Mesonephroma / Q000188:drug therapy*; D011882:Radiotherapy, High-Energy; D012208:Rhabdomyosarcoma / Q000188:drug therapy*; D013724:Teratoma / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use*; D009396:Wilms Tumor / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide